GE HealthCare Technologies (MEX:GEHC) LT-Debt-to-Total-Asset: 0.28 (As of Mar. 2026)


MEX:GEHC GE HealthCare Technologies Inc MEX:GEHC
63 GF Score
Price MXN1,149.89
GF Value MXN1,492.85
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is GE HealthCare Technologies LT-Debt-to-Total-Asset?

GE HealthCare Technologies MEX:GEHC 63 LT-Debt-to-Total-Asset is 0.28 as of Mar. 2026. GuruFocus rates MEX:GEHC with a GF Score™ of 63/100 and a GF Value™ of MXN1,492.85 (Modestly Undervalued). The stock has 4 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. GE HealthCare Technologies's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.28.

GE HealthCare Technologies's long-term debt to total assets ratio increased from Mar. 2025 (0.21) to Mar. 2026 (0.28). It may suggest that GE HealthCare Technologies is progressively becoming more dependent on debt to grow their business.

GE HealthCare Technologies  (MEX:GEHC) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

GE HealthCare Technologies LT-Debt-to-Total-Asset Related Terms

GE HealthCare Technologies LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for GE HealthCare Technologies's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GE HealthCare Technologies LT-Debt-to-Total-Asset Chart

GE HealthCare Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial 0.01 0.31 0.27 0.23 0.27

GE HealthCare Technologies Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.24 0.24 0.27 0.28
MEX:GEHC
63GF Score
GE HealthCare Technologies Inc MEX:GEHC
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GE HealthCare Technologies LT-Debt-to-Total-Asset Calculation

GE HealthCare Technologies's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )/Total Assets (A: Dec. 2025 )
=176833.98/664518.365
=0.27

GE HealthCare Technologies's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=188225.323/669463.988
=0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.28 mean?
GE HealthCare Technologies (MEX:GEHC) has a LT-Debt-to-Total-Asset of 0.28 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on GE HealthCare Technologies and its competitors.
Is GE HealthCare Technologies' LT-Debt-to-Total-Asset too high?
GE HealthCare Technologies' current LT-Debt-to-Total-Asset is 0.28. Overall, GE HealthCare Technologies has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GE HealthCare Technologies' LT-Debt-to-Total-Asset compare to DXCM and STE?
GE HealthCare Technologies' LT-Debt-to-Total-Asset of 0.28 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?
A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on GE HealthCare Technologies and its competitors. GE HealthCare Technologies's current LT-Debt-to-Total-Asset is 0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GE HealthCare Technologies stock overvalued right now?
Based on GuruFocus' analysis, GE HealthCare Technologies (MEX:GEHC) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,492.85, compared to a current price of MXN1,149.89 — trading 23% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.28. GE HealthCare Technologies' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For GE HealthCare Technologies (MEX:GEHC), the current LT-Debt-to-Total-Asset is 0.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GE HealthCare Technologies (MEX:GEHC) Overvalued in 2026?

Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued. The current stock price of MXN1,149.89 is trading 23% below its estimated GF Value™ of MXN1,492.85. GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.

Key valuation signals for MEX:GEHC:

  • LT-Debt-to-Total-Asset: 0.28
  • GF Value™: MXN1,492.85 vs. price of MXN1,149.89 (23% below fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the MEX:GEHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GE HealthCare Technologies Business Description

Address 500 West Monroe Street, Chicago, IL, USA, 60661
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
63GF Score

Get the complete analysis for MEX:GEHC

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,149.89
Price
MXN1,492.85
GF Value